Display Settings:

Format

Send to:

Choose Destination
    Breast Cancer Res. 2002;4(6):209-12. Epub 2002 Oct 3.

    Prolactin signaling and Stat5: going their own separate ways?

    Source

    Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland. Cathrin.Brisken@isrec.unil.ch

    Abstract

    Miyoshi et al. compared the role of the prolactin receptor (PrlR) and its downstream mediator, the signal transducer and activator of transcription 5 (Stat5), in mammary epithelial cells in vivo by studying PrlR-/- and Stat5ab-/- mouse mammary epithelial transplants during pregnancy. At first glance, the two mutant epithelia appear to have similar defects in the differentiation of the alveolar epithelium. However, a closer examination by Miyoshi et al. revealed defects in the epithelial architecture of the smallest ducts of Stat5ab-/- transplants not apparent in the PrlR-/- transplants, suggesting that Stat5 is more than a simple mediator of PrlR action.

    PMID:
    12473164
    [PubMed - indexed for MEDLINE]
    PMCID: PMC137942
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Click here to read Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk